News and Events

05/2019: High Ranking Delegation from China
UGA Biopharma welcomed 28 delegates from China. Representatives from chinese health institutes more

05/2019: ESACT Meeting in Copenhagen
On behalf of all UGA team members, we would like to thank all our customers and partners for their valuable and long-standing more

12/2017: Four projects successfully completed in Q4
Four biosimilar development projects were successfully finalized in Q4. Ready-to-use Research Cell Banks are available for out-licensing now! more

11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA. more

10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that more

09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this more

08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing more

07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging more

05/2017: UGA Biopharma presented at Bionnale 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services" more

04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made more

03/2017: Launch of High Speed Workflow
UGA has launched an improved cell-line-development workflow ("High Speed Workflow"), which guarantees cell line development on a shortened time more


UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900